Novel Treatment Strategies and Latest Evidence for Metastatic CastrationSensitive Prostate Cancer

Chair, Matthew R. Smith, MD, PhD, Karim Fizazi, MD, PhD, and Sandy Srinivas, MD, discuss castrationsensitive prostate cancer in this CME/MOC activity titled “Realizing the Potential of Novel Treatment Intensification Strategies for Metastatic CastrationSensitive Prostate Cancer: The Experts’ Take on Key Clinical Evidence, Practical Considerations, and Best Practices for Individualized, PatientCentered Care.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/UDM865. CME/MOC credit will be available until July 5, 2023.